Clinical trial
An Eight-Week, Randomized, Double-Blind Comparison of Guanfacine, Focalin XR, and the Combination, With a Twelve Month Open-Label Extension for the Treatment of ADHD in Pediatric Subjects Aged 7 to 14 Years
NCT00429273 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Eight-Week, Randomized, Double-Blind Comparison of Guanfacine, Focalin XR, and the Combination, With a Twelve Month Open-Label Extension for the Treatment of ADHD in Pediatric Subjects Aged 7 to 14 Years
- Lead sponsor
- University of California, Los Angeles
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- July 31, 2011
- Enrollment
- 212 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.